Evidence map›Paper›PMID 34746008›Full record

ReviewFrontiers in oncology2021

Gastrointestinal Cancers and Liver Cirrhosis: Implications on Treatments and Prognosis.

Ze Xiang, Yiqi Li, Chaojie Zhu, Tu Hong, Xianglin He, Hua Zhu, Danbin Jiang

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ze XiangDepartment of Gastroenterology, Yancheng Third People's Hospital, Yancheng, China.
Yiqi LiSchool of Medicine, Zhejiang University, Hangzhou, China.
Chaojie ZhuSchool of Medicine, Zhejiang University, Hangzhou, China.
Tu HongSchool of Medicine, Zhejiang University, Hangzhou, China.
Xianglin HeChu Kochen Honors College, Zhejiang University, Hangzhou, China.
Hua ZhuDepartment of Gastroenterology, Yancheng Third People's Hospital, Yancheng, China.
Danbin JiangDepartment of Gastroenterology, Yancheng Third People's Hospital, Yancheng, China.
Zhejiang University · CNYancheng Third People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver cirrhosis tends to increase the risk in the management of gastrointestinal tumors. Patients with gastrointestinal cancers and liver cirrhosis often have serious postoperative complications and poor prognosis after surgery. Multiple studies have shown that the stage of gastrointestinal cancers and the grade of cirrhosis can influence surgical options and postoperative complications. The higher the stage of cancer and the poorer the degree of cirrhosis, the less the surgical options and the higher the risk of postoperative complications. Therefore, in the treatment of patients with gastrointestinal cancer and liver cirrhosis, clinicians should comprehensively consider the cancer stage, cirrhosis grade, and possible postoperative complications. This review summarizes the treatment methods of patients with different gastrointestinal cancer complicated with liver cirrhosis.

Indexed as

cancer treatmentgastrointestinal cancerliver cirrhosispostoperative complicationsprognosis

Identifiers

PMID34746008
PMCPMC8567751
OpenAlexW3209141956

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.